shutterstock_1173953113_360b
360b / Shutterstock.com
2 May 2019Big Pharma

AstraZeneca partners on AI drug discovery collaboration

AstraZeneca has begun collaborating with UK-headquartered artificial intelligence (AI) company  BenevolentAI to use AI and machine learning for the discovery and development of new treatments.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
21 January 2019   Novartis and the University of Oxford’s Big Data Institute have joined forces to use artificial intelligence for improving drug development, initially in the areas of multiple sclerosis, dermatology and rheumatology.
Big Pharma
9 September 2019   Swiss pharmaceutical company Novartis has united with BenevolentAI to aid in the discovery and development of new treatments.
Big Pharma
11 November 2019   AstraZeneca is planning to build a new global research and development centre in China.

More on this story

Big Pharma
21 January 2019   Novartis and the University of Oxford’s Big Data Institute have joined forces to use artificial intelligence for improving drug development, initially in the areas of multiple sclerosis, dermatology and rheumatology.
Big Pharma
9 September 2019   Swiss pharmaceutical company Novartis has united with BenevolentAI to aid in the discovery and development of new treatments.
Big Pharma
11 November 2019   AstraZeneca is planning to build a new global research and development centre in China.

More on this story

Big Pharma
21 January 2019   Novartis and the University of Oxford’s Big Data Institute have joined forces to use artificial intelligence for improving drug development, initially in the areas of multiple sclerosis, dermatology and rheumatology.
Big Pharma
9 September 2019   Swiss pharmaceutical company Novartis has united with BenevolentAI to aid in the discovery and development of new treatments.
Big Pharma
11 November 2019   AstraZeneca is planning to build a new global research and development centre in China.